[ 5/9 (수) ]
KPAC 2018 (Korea Pharma Associations Conference/한국제약산업공동컨퍼런스)
담당자 정보 | 임현희, +82-2-6263-2058, hyunhee.leem@mci-group.kr |
---|
시간 | 주제 |
---|---|
12 : 00 ~ 13 : 30 | Policy luncheon RTM (Invitation Only) |
13 : 30 ~ 14 : 10 | Opening Remarks |
14 : 10 ~ 14 : 25 | Congratulatory Remarks |
14 : 25 ~ 14 : 30 | Photo Time |
14 : 30 ~ 15 : 10 | Keynote Speech (MNC : Cutting edge in new drug R&D with open innovation) |
Philip Tagari, VP of Research, AMGEN | |
패널토론 | |
15 : 10 ~ 16 : 20 | Session 1: Future of Oncology Biomarkers and How Open Innovation Works |
Rosa Hee Jung Kim, Senior Manager, AstraZeneca | |
Hunwoo Shin, Director, BD&L, MSD | |
Byoung Chul Cho, Severance Hospital | |
16 : 40 ~ 17 : 50 | Session 2: Implement 'Quick win fast fail strategy' for new drug R&D |
Takao Honda, Sr. Manager, External Innovation, Eli Lilly Japan | |
Su Jin Ahn, Director, Yuhan | |
Hyun Ju Yang, Executive Director), Daiichi Sankyo Korea |